Search Immortality Topics:

Page 12«..11121314..2030..»


Category Archives: Biotechnology

Digital Genome Engineering Market Size and Industry Analysis 2022 : Biotechnology Revolution to Boom the Digital Genome Business with Latest Research…

Digital Genome Engineering Market Size and Share is Estimated to Growth by US$ 60.35 at CAGR 11.1% during Forecast period 2028

This press release was orginally distributed by SBWire

Londan, United kingdom (SBWIRE) 06/06/2022 Digital Genome Engineering is a comprehensive digital set of genetic material that occurs in a cell or an organism. It allows experts to get a nearer look at genetic disorders, with instant access to sequence data and tools to resolve unending custom queries. Thus, the aforementioned parameters will augment the market growth. Digital Genome Engineering deals with genes & their functions and assists in finding causes behind chronic disorders and also to resolve them. This technology has sparked a revolt in invention-centred research & systems biology to expedite insight of the most complex genetic systems.

The global Digital Genome Engineering market research report provides an in-depth analysis of the existing and future state of the industry. The study comprises all market data and is based on extensive primary and secondary research. Statistics by type, industry, channel, and other parameters are included in the analysis, as well as market volume and value for each category. The coronavirus pandemic has an influence on the global economy. Several market conditions have shifted. The market is fast evolving, according to the study report, and its influence is being studied both now and in the future.

Get a Sample Report of Digital Genome Engineering Market @ https://www.intelligencemarketreport.com/report-sample/486645

The study offers exact figures for the industry's market size, share, production capacity, demand, and growth for the anticipated year. This is the most recent market effect analysis research for COVID-19. The Digital Genome Engineering market research looks at the market's top businesses, distributors, and the entire structure of the industrial chain. It also evaluates the aspects and criteria that may have an impact on market expansion.

The Major Key Company Profiles included in Digital Genome Engineering market study are:

-Abbott Laboratories-Agilent Technologies Inc-Becton, Dickinson and Company-Biomerieux SA-Bio-rad Laboratories Inc-Roche-Illumina Inc-Inscripta-Oxford Nanopore Technologies Ltd-Pacific Bioscience-Perkinelmer Inc-Qiagen NV-Regeneron Pharmaceuticals-Thermo Fisher Scientific Inc

Market Segmentation

The research looks on the industry's growth goals, cost awareness, and manufacturing procedures. Market segmentation by product type, application, end-user, and geography is discussed in the Digital Genome Engineering research report. A basic industry overview, as well as categorization, definition, and, as a result, the supply and demand chain structure, are included in the market study. Global research includes global marketing data, competitive climate surveys, growth rates, and critical development status information.

Russia-Ukraine War Impact on Digital Genome Engineering Market

The impact of the Russia-Ukraine conflict on the worldwide market is covered in the research study. While tensions between Russia and Ukraine have been increasing for years, the present military action heightens fears of a long-term conflict within Ukraine, as well as market and global economic implications. The market research report covers whether this ongoing conflict is making any of on target market or not.

The Digital Genome Engineering Market Segments and Sub-Segments are Listed Below:

Segmentation by type:

-Miss Target Assessment-Target Efficiency Prediction-Typing Efficiency Prediction-Measurement of Editing Efficiency of Target Genome-Other

Segmentation by application:

-Hospital-Research Institute-Institutions of Higher Learning

Do you have any query regarding this research? Ask your Query @ https://www.intelligencemarketreport.com/send-an-enquiry/486645

Regional Analysis

From production and consumer ratios to market size and market share, import and export ratios, supply and demand, consumer demand ratios, technological advancements, research and development, infrastructure development, economic growth, and a strong market presence in every region, research covers everything. Geographic study will assist players in discovering profitable markets where they may capitalize on fresh opportunities. The Digital Genome Engineering market is divided into five regions: North America, Latin America, Europe, Asia Pacific, and the Rest of the World.

Competitive Outlook

The research report covers financial conditions, global positioning, product portfolios, income and gross profit margins, as well as technology and research breakthroughs. The Digital Genome Engineering market research focuses on the industry's most notable acquisitions, collaborations, and product launches. To provide deeper insights into key players, the study report incorporates modern research approaches such as SWOT and Porter's Five Forces analysis. The study provides a comprehensive assessment of the global competitive climate as well as critical insights into the major competitors and their expansion plans.

Table of Contents Major Key Points

1 Scope of the Report2 Executive Summary3 Digital Genome Engineering Market Size by Player4 Digital Genome Engineering by Regions5 Americas6 APAC7 Europe8 Middle East & Africa9 Market Drivers, Challenges and Trends10 Global Digital Genome Engineering Market Forecast11 Key Players Analysis12 Research Findings and Conclusion

Buy Single User PDF of Digital Genome Engineering Market @ https://www.intelligencemarketreport.com/checkout/486645

About Us:

Intelligence Market Report includes a comprehensive rundown of statistical surveying reports from many distributers around the world. We brag an information base traversing basically every market classification and a much more complete assortment of statistical surveying reports under these classifications and sub-classifications.

Intelligence Market Report offers premium reformist factual looking over, statistical surveying reports, investigation and gauge information for businesses and governments all throughout the planet.

For more information on this press release visit: http://www.sbwire.com/press-releases/digital-genome-engineering-market-size-and-industry-analysis-2022-biotechnology-revolution-to-boom-the-digital-genome-business-with-latest-research-development-1358631.htm

More here:
Digital Genome Engineering Market Size and Industry Analysis 2022 : Biotechnology Revolution to Boom the Digital Genome Business with Latest Research...

Posted in Biotechnology | Comments Off on Digital Genome Engineering Market Size and Industry Analysis 2022 : Biotechnology Revolution to Boom the Digital Genome Business with Latest Research…

Millig Design Build President is Speaker at 2022 ISPE Biotechnology Conference on Sustainability in the Biopharmaceutical Industry – PR Newswire

Scott McVey, president of Millig Design Build, an expert in decarbonization, to speak at ISPE Biotechnology Conference.

"It's an honor to be invited to deliver this presentation at the ISPE Biotechnology Conference," said McVey. "The biopharmaceutical sector has bold, ambitious carbon reduction targets. This event is the perfect opportunity to share specific steps the industry can take now to achieve its Net Zero goals."

McVey's presentation will focus on the challenges the biopharmaceutical sector faces in achieving Net Zero carbon emissions; the technologies available today that can safely replace the fossil fuels the industry uses for electricity and manufacturing processes; and the steps the sector needs to take now to achieve Net Zero by 2050.

Unlike the majority of the manufacturing sector, where most energy consumption comes from process heat, 65 percent of energy consumption in the biopharmaceutical sector arises from stringent environmental conditioning requirements like indoor temperature, relative humidity, air change rate, room pressurization, filtration, and ventilation. Millig Design Build has developed a sequence strategy the biopharmaceutical sector can deploy to meet stringent environmental conditioning requirements and ensure safety and quality, while reducing Scope 1 and 2 carbon emissions associated with electricity and fuel use.

"As a design-build firm, Millig is uniquely positioned to decarbonize critical environments like those found in biopharmaceutical facilities," said McVey. "We deliver value far beyond a decarbonization plan. We provide an actionable roadmap for long-term decarbonization, and we're able to immediately design and install the solutions we identify during our initial analysis phase."

About Millig Design BuildMillig Design Build is an integrated engineering, design, and construction firm specializing in facility improvements that address energy efficiency, building health and safety, and core infrastructure needs. Our mission is to create environments that promote sustainability, wellbeing, and opportunity for communities while efficiently delivering best-value solutions for owners. We have offices in Kansas; Colorado; Oregon; Washington; and Vancouver, Canada. For more information, visit http://www.milligdb.com.

Media Contact Information:Amy McVeyMillig Design BuildPhone: 785-865-6054E-mail: [emailprotected]

SOURCE Millig Design Build

Read more:
Millig Design Build President is Speaker at 2022 ISPE Biotechnology Conference on Sustainability in the Biopharmaceutical Industry - PR Newswire

Posted in Biotechnology | Comments Off on Millig Design Build President is Speaker at 2022 ISPE Biotechnology Conference on Sustainability in the Biopharmaceutical Industry – PR Newswire

The Biotechnology Services Market Is Expected To Reach $267 Billion By 2026 Due To A Rapid Increase In Lifestyle And Chronic Diseases As Per The…

LONDON, April 21, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Companys research report on the biotechnology services market, the biotechnology services market is expected to grow rapidly due to increasing lifestyle and chronic diseases. This is mainly due to unhealthy lifestyles, a growing aging population, rising inactivity and obesity. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally by the year 2020. China and India together had about 193.4 million diabetic patients in 2019, and India is expected to have about 101 million diabetic patients by 2030. In the field of mental health, the World Health Organization predicts that one in every four people will beaffected by a type of mental disorder such as depression, schizophrenia, or anxiety in the future. In response to this, national governments across the globe are rapidly increasing their medical research expenditure. The world's population is also growing older with every passing year.

For instance, worldwide, the average life expectancy is expected to rise from 73 years to 74.1 years between 2016 and 2021. Based on this estimate, 11.5% of the world population will be over 65 years of age by 2021. Additionally, due to the increased consumption of processed foods, chronic health conditions like diabetes are expected to become more common. Therefore, increasing investment in medical research to treat chronic diseases is further driving the demand for biotechnology services.

The global biotechnology services market is expected to grow from $129.14 billion in 2021 to $151.10 billion in 2022 at a compound annual growth rate (CAGR) of 17.0%. The growth in the market is mainly due to companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. TBRCs biotechnology services market growth analysis states that the market is expected to reach $267.29 billion in 2026 at a CAGR of 15.3%.

Request for a sample of the global biotechnology services market report

The development of automated solutions for devices and equipment is gaining popularity among biotechnology services market trends. Automation of the process will help to enhance productivity and consistency of the whole diagnostic process, along with reducing contact points for samples, consumables, and liquid handling, which improves the safety of clinical and laboratory personnel. In 2019, Thermo Fisher Scientific, based in Massachusetts, USA, a major player in the market, introduced a new benchtop automated reading and incubation system for antimicrobial susceptibility testing (AST). This new instrument will provide microbiology laboratories with accurate minimum inhibitory concentration (MIC) results that are needed by clinicians to confidently select an effective antibiotic for critically ill patients while safeguarding future patient care through more successful antimicrobial stewardship.

Major players in the biotechnology services market are Novartis, Fisher BioService, Pfizer, Novo Nordisk, BioAlps, Precision for Medicine, Sartorius and Aldevron.

The global biotechnology services market segmentation is categorized by service into prevention and disease control, public engagement activities, health education and research, food biotechnology services, donor recruitment, tissue collection, cell processing and isolation, research and development; by industry into Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), Contract Research and Manufacturing Services (CRAMS); by area of application into pharmaceutical, biotechnological, academic, clinical trial, healthcare sectors.

As per the biotechnology services industry overview, in 2021, Asia Pacific was the largest region in the market. North America was the second largest region in the biotechnology services market. The regions covered in the biotechnology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Biotechnology Services Global Market Report 2022 Market Size, Trends, And Global Forecast 2022 2026 is one of a series of new reports from The Business Research Company that provide biotechnology services market overviews,biotechnology services market analyze and forecast market size and growth for the whole market, biotechnology services market segments and geographies,biotechnology services market trends, biotechnology services market drivers,biotechnology services market restraints,biotechnology services market leading competitors revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.

The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors approaches.

Not the market you are looking for? Check out some similar market intelligence reports:

Diabetes Care Devices Global Market Report 2022 By Type (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type Of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) Market Size, Trends, And Global Forecast 2022-2026

Biosimulation Global Market Report 2022 By Product (Software, Services), By Application (Drug Development, Drug Discovery), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Regulatory Authorities, Academic Research Institutions) Market Size, Trends, And Global Forecast 2022-2026

Laboratory Automation Systems Global Market Report 2022 By Equipment & Software (Automated Liquid Handling, Microplate Readers, Standalone Robots, Automated Storage And Retrieval Systems, Software And Informatics, Other Equipment), By Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions, Other Applications), By End User (Biotechnology And Pharmaceutical Industries, Research Institutes, Hospitals And Private Labs, Academic Institutes), By Type (Modular Automation, Total Lab Automation) Market Size, Trends, And Global Forecast 2022-2026

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The Worlds Most Comprehensive Database

The Business Research Companys flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Read the rest here:
The Biotechnology Services Market Is Expected To Reach $267 Billion By 2026 Due To A Rapid Increase In Lifestyle And Chronic Diseases As Per The...

Posted in Biotechnology | Comments Off on The Biotechnology Services Market Is Expected To Reach $267 Billion By 2026 Due To A Rapid Increase In Lifestyle And Chronic Diseases As Per The…

Master of Science in Biotechnology and Bioinformatics at IBAB Bengaluru – Mathrubhumi English

Institute of Bioinformatics and Applied Biotechnology (IBAB), Biotech Park, Electronics City Phase I, Bengaluru 560 100 has invited applications for admission to the 2 years Master of Science in Biotechnology and Bioinformatics Program 2022-24.

The MSc programme in Biotechnology and Bioinformatics is an interdisciplinary programme that positions one at the cutting edge of basic and applied science, in particular in the research field and a unique dual specialization degree programme that builds competence in both biotechnology and computational biology/ bioinformatics.

Students of this programme are provided extensive training in cell and molecular biology, genome editing, computer science, mathematics, statistics, bioinformatics and so on. Right from the beginning, the faculty ensures that the students get an immersive high quality research experience. They also get several opportunities to meet and interact with high-profile scientists from across the globe. Events such as the annual Kiran Mazumdar-Shaw Lecture series have enabled the visit of a Nobel laureate.

Eligibility: Applicant should hold Bachelors degree in any branch of science/technology/medicine such as Life sciences (zoology, botany, genetics, human biology, general life sciences, ecology, environmental biology), bioinformatics, biotechnology, chemistry, physics, mathematics, statistics, any branch of engineering, pharmaceutical sciences, agriculture, medicine, dentistry, horticulture, forestry and veterinary sciences, with degrees such as BSc, BE, BTech, BPharm, MBBS, BDS and BVSc etc. Applicant should have obtained at least 50% marks overall in Bachelors programme. There is no age bar for applying. Applicants who have had a break in their education or have been working for a few years are also eligible. Indian nationals, NRIs and foreign nationals who have passed the qualifying degree examination outside of India, must submit the Equivalence Certificate issued by the Association of Indian Universities along with their application.

Applicants will be short listed based on a proctored online examination. The details will be intimated later. The entrance test to the MSc in Biotechnology and Bioinformatics (20222024) will cover the subjects Physics, Mathematics, Chemistry, and the Life sciences. The details of the syllabus and pattern will be updated on the web page. Any change in the examination pattern will be intimated to the applicants.

The short listed candidates will be interviewed either in person at IBAB, or in online mode. Candidates will be intimated in due course about the date and mode of interview.A scholarship will be awarded based on the performance of the student each year, and the financial need of the student.

Application can be submitted online through the link available in the Program Notification at Announcements link at https://www.ibab.ac.in/ latest by 7.5.2022.Application fee is Rs. 600/-. Mock test (online, can be taken from anywhere) will be held on 15 May 2022. Entrance Test (online, proctored) will be conducted on 22 May 2022. Personal Interview will be between 06 June-16 June 2022. Course Commences on 18 July 2022. For details, visit https://www.ibab.ac.in/

Visit link:
Master of Science in Biotechnology and Bioinformatics at IBAB Bengaluru - Mathrubhumi English

Posted in Biotechnology | Comments Off on Master of Science in Biotechnology and Bioinformatics at IBAB Bengaluru – Mathrubhumi English

PDS Biotechnology Co. (NASDAQ:PDSB) Given Consensus Recommendation of Buy by Analysts – Defense World

PDS Biotechnology Co. (NASDAQ:PDSB Get Rating) has been given a consensus rating of Buy by the eight research firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and six have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $21.20.

Separately, StockNews.com upgraded shares of PDS Biotechnology to a sell rating in a research report on Saturday, April 9th.

NASDAQ:PDSB opened at $5.16 on Monday. The firms 50 day simple moving average is $5.95 and its 200 day simple moving average is $7.99. PDS Biotechnology has a one year low of $4.10 and a one year high of $17.85.

Large investors have recently added to or reduced their stakes in the company. Voloridge Investment Management LLC increased its stake in shares of PDS Biotechnology by 279.2% in the 3rd quarter. Voloridge Investment Management LLC now owns 49,191 shares of the companys stock valued at $733,000 after acquiring an additional 36,219 shares in the last quarter. Trexquant Investment LP bought a new stake in shares of PDS Biotechnology in the 3rd quarter valued at $632,000. Cubist Systematic Strategies LLC increased its stake in shares of PDS Biotechnology by 187.0% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 71,618 shares of the companys stock valued at $1,067,000 after acquiring an additional 46,665 shares in the last quarter. Jump Financial LLC bought a new stake in shares of PDS Biotechnology in the 3rd quarter valued at $393,000. Finally, Valeo Financial Advisors LLC increased its stake in shares of PDS Biotechnology by 35.7% in the 4th quarter. Valeo Financial Advisors LLC now owns 21,570 shares of the companys stock valued at $175,000 after acquiring an additional 5,670 shares in the last quarter. Institutional investors own 23.91% of the companys stock.

PDS Biotechnology Company Profile (Get Rating)

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer.

Featured Stories

Receive News & Ratings for PDS Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PDS Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.

Read more:
PDS Biotechnology Co. (NASDAQ:PDSB) Given Consensus Recommendation of Buy by Analysts - Defense World

Posted in Biotechnology | Comments Off on PDS Biotechnology Co. (NASDAQ:PDSB) Given Consensus Recommendation of Buy by Analysts – Defense World

Ukraine war exposes EU’s organic obsession and biotechnology rejectionism – Genetic Literacy Project

Beyond needless loss of life, the war in Ukraine has caused a trade war that could slash global food production, taking the greatest toll on the poorest of us. The silver lining: this tragic situation may inspire some long-overdue policy reforms.

The world is in a precarious place. Besides the fact that several thousand people have already been killed and millions more displaced, the war in Ukraine has triggered a trade war that could do severe damage to farmers and consumers around the world. A handful of wealthy celebrities have celebrated this development, urging the rest of us to endure skyrocketing gas and food prices if it means putting the screws to Putin, as Stark Trek actorGeorge Takeiso unhelpfully put it.

Comments like that play well on Twitter, but they ignore two important points everybody should recognize. Vladimir Putin wont miss any meals because of the economic measures aimed at Russia, but lots of poor people worldwide will go hungry. If there is an upside to this war, its that the subsequent food price hikes and shortages have exposed the folly of Europesprotectionistanti-GMO policies.

Russia and Ukraineproduce just over30 percent of the worlds wheat. Dozens of developing countries count on those exports to feed themselves, and they could suffer devastating consequences if the war and resulting economic sanctions continue to disrupt global trade.

Retired US Army Colonel Douglas MacGregorrecently pointed outthat the Russian army has so far avoided the center of Ukraine, where most of the countrys crops are grown. Thats important over the long term, though farmers may not be able to plant anything this year. Even if they get crops in the ground, their production will be limited because the seed, fertilizer, fuel, and other inputs they need wont be delivered with Russian troopssurroundinga major port city like Mariupol, where a lot of imported goods enter Ukraine.

This is concerning since the United Nations World Food Program (WFP),which helps combat food insecurity primarily in northern African countries, buys about half its wheat from Ukraine. The WFP will either have to pay higher prices to other wheat exporters or buy less grain, and that could mean millions or potentially tens of millions more people transitioning into food insecurity, University of Saskatchewan agricultural economistStuart Smythtold ACSH during a recent interview.

The situation in Russia could have a similarly troubling impact. A few weeks ago, the country got skittish about the quick pace of its grain exports to neighboring ex-Soviet countries,Reuters reported, and moved to slow it down to protect the domestic food market in the face of external constraints, primarily Western sanctions.

That means higher grain prices globally, but the ensuing trade war will have further effects. Russiahas slashedexports of fertilizers that growers around the world depend on. Brazila major exporter of soybeans, coffee, and sugarwas already having trouble acquiring all the crop nutrients it needed before the war broke out. Exacerbated shortages will likely further inflate the prices of these commodities.

And because Russia is home tolarge mineral depositsfound in few other parts of the world, replacing the countrys fertilizer output could take several years, if its even possible. Argentina, another agricultural powerhouse, hascapped soy and corn exportsto shield its population from higher food prices in response to the fertilizer shortage, economist David Stockman noted last week. Overall, were talking about double-digit increases. As Olivier de Matos, director-general of CropLife Europe,wrote on March 17:

Escalating food prices that are already plaguing consumers around the world look set to get much worse. The United Nations has warned that already record global food costs could increase by a further 22% as the war stifles international trade and decimates future harvests.

Before Russian tanks rolled into Ukraine, The European Union was poised to implement its Farm-To-Fork program, whichaimed tocut pesticide use by 50 percent and commit 25 percent of Europes farmland to organic food production by 2030. This was alwaysa misguided plan; now its a pipe dream, and the EU knows it. Policymakers areworking to relaximport restrictions on transgenic (GMO) crops that farmers need for animal feed, an increase beyond the30 million metric tonsof genetically engineered soy Europe already imports.

This is a positive step in the grand scheme of things, and it may finally push Europe into letting farmers grow the biotech crops its regulators knowpose no riskto human health or the environment. It gives governments an opportunity to take a hard look at the underlying rationale for prohibiting GM crop cultivation in the first place, Smyth added. I think some governments are going to say, That time has passed, and we need to change our policies.

Heres to hoping the EU takes Smyths adviceand that this war comes to an end sooner rather than later.

Cameron English is a writer, editor and co-host of the Science Facts and Fallacies Podcast. Before joining ACSH, he was managing editor at the Genetic Literacy Project, a nonprofit committed to aiding the public, media, and policymakers by promoting science literacy. You can visit Camerons website here

A version of this article was posted at American Council on Science and Health and is used here with permission. You can check out the American Council on Science and Health on Twitter @ACSHorg

Read the original post:
Ukraine war exposes EU's organic obsession and biotechnology rejectionism - Genetic Literacy Project

Posted in Biotechnology | Comments Off on Ukraine war exposes EU’s organic obsession and biotechnology rejectionism – Genetic Literacy Project